Recombinetics
St. Paul, US
Biotech
Founders & leadership
MB
Mark B. Kroll, Ph.D.Director
JF
John F. CameronExecutive Officer
DF
David F. AberleExecutive Officer
PB
Peter B. HajasDirector
SC
Scott C. Fahrenkrug, Ph.D.Director, Promoter
JF
Justin F. ZenankoExecutive Officer
TL
Tammy Lee StanochExecutive Officer
JB
Jim B. KilmanDirector
WB
Wendell B. KingDirector
RB
Robert B. SwitzDirector
ML
Mitchell Lee Abramhamsen, Ph.D.Executive Officer, Director
PB
Perry B. Hacket, Ph.D.Director
Reported raises · per SEC filings
Form D private placements$7.7MraisedFeb 2019 · 11 investors · Biotechnology
Rule 506(b)$33.5MraisedSep 2018 · 14 investors · Biotechnology
Rule 506(b)$6.4MraisedMar 2018 · 47 investors · Biotechnology
Rule 506(b)$630KraisedAug 2016 · 7 investors · Biotechnology
Rule 506(b)$5.7MraisedJul 2016 · 89 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.